<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Popular weight-loss drugs face numerous lawsuits over rare ‘eye stroke’ linked to vision loss — Live Feed</title><link>https://www.live-feeds.com/feed/popular-weight-loss-drugs-face-numerous-lawsuits-over-rare-eye-stroke-linked-to-vision-loss</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/popular-weight-loss-drugs-face-numerous-lawsuits-over-rare-eye-stroke-linked-to-vision-loss/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Weight-Loss Drugs Face Lawsuits Over Rare Eye Stroke</title><link>https://www.live-feeds.com/feed/popular-weight-loss-drugs-face-numerous-lawsuits-over-rare-eye-stroke-linked-to-vision-loss</link><guid isPermaLink="false">https://www.live-feeds.com/feed/popular-weight-loss-drugs-face-numerous-lawsuits-over-rare-eye-stroke-linked-to-vision-loss#u82601</guid><pubDate>Thu, 24 Sep 2026 12:20:10 +0000</pubDate><description>Hundreds of patients are filing lawsuits against the manufacturers of popular GLP-1 receptor agonist medications, alleging the drugs caused a rare and severe form of vision loss known as an eye stroke. The legal actions target widely used treatments for weight loss and diabetes, focusing on whether drugmakers failed to adequately warn users about the potential risk of sudden blindness. Affected individuals are stepping forward to share their experiences of losing sight while on the medications, intensifying scrutiny on pharmaceutical companies producing these blockbusters.Why it mattersGLP-1 r</description></item>
</channel></rss>